← ANALYST RATINGS · TIPRANKS
Azenta (AZTA): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy1 Hold0 Sell
Ratings of 3 analysts in the last 3 months12-month forecast
Based on 3 price targets given in the last 3 months, the average target is $35.00, the highest $37.00, the lowest $33.00. The average is +2.7% from the last price of $34.09.
Analyst ratings 6
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $45.00 → $41.00−8.9% | Hold | +20.3% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $43.00 → $40.00−7.0% | Hold | +17.3% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $44.00 → $42.00−4.5% | Hold | +23.2% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $44.00 → $41.00−6.8% | Hold | +20.3% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $47.00 → $43.00−8.5% | Hold | +26.1% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $44.00 → $41.00−6.8% | Hold | +20.3% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $40.00 → $45.00+12.5% | Hold | +32.0% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $39.00 → $43.00+10.3% | Hold | +26.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $40.00 → $44.00+10.0% | Hold | +29.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $40.00 → $44.00+10.0% | Hold | +29.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $42.00 → $47.00+11.9% | Hold | +37.9% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $40.00 → $44.00+10.0% | Hold | +29.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $35.00 → $40.00+14.3% | Hold | +17.3% | Reiterated | 03.10.26on TipRanks 02:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $34.00 → $39.00+14.7% | Hold | +14.4% | Reiterated | 03.10.26on TipRanks 02:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $35.00 → $40.00+14.3% | Hold | +17.3% | Reiterated | 03.10.26on TipRanks 02:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $34.00 → $40.00+17.6% | Hold | +17.3% | Reiterated | 03.10.26on TipRanks 02:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $36.00 → $42.00+16.7% | Hold | +23.2% | Reiterated | 03.10.26on TipRanks 02:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $34.00 → $40.00+17.6% | Hold | +17.3% | Reiterated | 03.10.26on TipRanks 02:05 | — | |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $32.00 → $35.00+9.4% | Hold | +2.7% | Reiterated | 17.09.26on TipRanks 20:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $31.00 → $34.00+9.7% | Hold | −0.3% | Reiterated | 17.09.26on TipRanks 20:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $32.00 → $35.00+9.4% | Hold | +2.7% | Reiterated | 17.09.26on TipRanks 20:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $31.00 → $34.00+9.7% | Hold | −0.3% | Reiterated | 17.09.26on TipRanks 20:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $34.00 → $36.00+5.9% | Hold | +5.6% | Reiterated | 17.09.26on TipRanks 20:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $32.00 → $34.00+6.2% | Hold | −0.3% | Reiterated | 17.09.26on TipRanks 20:05 | — | |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $37.00 | Buy | +8.5% | Reiterated | 14.09.26on TipRanks 10:11 | +4.3%next day +3.5% · 5 days +3.4% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $28.00 → $35.00+25.0% | Buy | +2.7% | Reiterated | 06.08.26on TipRanks 07:56 | −3.2%next day +3.6% · 5 days +9.1% | ↗ |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | $20.00 → $33.00+65.0% | Hold | −3.2% | Reiterated | 05.08.26on TipRanks 14:50 | +5.8%next day −3.2% · 5 days +5.0% | ↗ |
| Matthew Stanton, CFA★★★★★★★★★★#10524 · hits 43% · avg −10.9% | Jefferies | $40.00 → $35.00−12.5% | Buy | +2.7% | Reiterated | 01.04.26on TipRanks 14:05 | −0.5%next day +6.8% · 5 days +3.2% | ↗ |
| Andrew Cooper★★★★★★★★★★#11107 · hits 40% · avg −3.0% | Raymond James | $35.00 → $45.00+28.6% | Buy | +32.0% | Reiterated | 25.11.25on TipRanks 11:40 | +2.9%next day −5.5% · 5 days −7.9% | ↗ |
| Thomas DeBourcy★★★★★★★★★★#7610 · hits 100% · avg +34.1% | Nephron | $31.00 | Hold | −9.1% | Upgrade | 24.11.25on TipRanks 08:45 | +3.7%next day +2.9% · 5 days −6.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Azenta
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $35.00 at a price of $34.89 (+0.3%); now: $35.00 at $34.09 (+2.7%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 2 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 17.11.26 (Q4 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.12 (from $0.05 to $0.15). Last quarter: $0.16.
Sales
Next quarter’s sales estimate — $160M (from $158M to $162M). Last quarter: $161M.
Best top-analyst consensus in the sector · Healthcare
About Azenta
- CEO: Martin D. Madaus
- Employees: 2,900
- 200 Summit Drive, Burlington, MA, 01803, US
- www.azenta.com
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Data from the stock’s TipRanks forecast page, read 135 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗